Gut-brain Axis
14 articles on Gut-brain Axis, researched and written by the Shotlee Editorial Team from primary sources.
Fat Jabs Slash Alcohol-Related Hospitalisations by More Than a Quarter
Recent analysis indicates that GLP-1 weight loss medications significantly reduce the risk of alcohol-related hospital admissions by approximately 26 percent compared to other diabetes treatments.
8 min read
Beyond the Hype: Understanding GLP-1s and Weight Management
The rise of GLP-1 medications has revolutionized weight management. This comprehensive guide delves into semaglutide, tirzepatide, and other peptide therapies, offering insights into their efficacy, potential side effects, and how to track your progress effectively.
7 min read
Beyond Weight Loss: The Expanding Horizon of GLP-1 Therapies
GLP-1 agonists, famously known for Ozempic and Wegovy, are making waves beyond their initial indications. While weight loss and diabetes management remain key, researchers are uncovering a broader therapeutic potential for these powerful peptide therapies.
8 min read
Beyond Appetite: How GLP-1 Drugs May Be Rewiring the Human Brain
GLP-1 receptor agonists, initially celebrated for revolutionizing diabetes and weight management, are now at the center of an unplanned, massive neuroscience experiment. Emerging data suggests these powerful medications are doing more than just regulating metabolism; they appear to be structurally and functionally altering key brain systems.
7 min read
What Happens to Your Body When You Take a GLP-1 Medication?
GLP-1 medications like Ozempic and Wegovy have transformed weight loss. But what exactly happens inside your body? We break down the science, mechanisms, and sustainability of peptide therapy.
8 min read
Duodenal Resurfacing: A New Hope Beyond GLP-1 Weight Loss?
The emergence of GLP-1 receptor agonists has revolutionized obesity treatment, but concerns about weight regain upon discontinuation are significant. New research on duodenal mucosal resurfacing suggests a potential breakthrough in maintaining weight loss long-term.
7 min read
Gut Reset Era 2026: Redefining Weight Loss and Digestive Health
In 2026, the gut reset era is transforming weight loss by linking it inseparably to digestive health and metabolism. No longer isolated goals, bloating, slow metabolism, and weight gain are addressed holistically for lasting results. From microbiome breakthroughs to personalized tech tools, this integrated approach promises better outcomes.
7 min read
Kerry: Consumer Mindset Shifts and GLP-1s Drive Gut Health Innovations
Consumers are shifting from short-term fixes to proactive long-term gut health strategies, accelerated by GLP-1 medications, according to Kerry representatives Mathieu Millette, Ph.D., and Haelim Choi. Kerry research highlights top-valued benefits, while GLP-1 demand drives GI support innovations, including biotics tested in human trials to counter side effects.
5 min read
SNAC in Ozempic and Wegovy Tablets Raises Gut Health Questions, Study Finds
New research uncovers potential effects of SNAC—the hidden ingredient enabling Ozempic and Wegovy tablets—on gut health. In a 21-day animal study, repeated exposure led to shifts in harmful gut bacteria, elevated inflammation, and depleted cognitive proteins. While not proving harm in humans, findings urge caution as oral semaglutide use surges.
6 min read
Study Flags Gut Risks from SNAC in Oral Weight-Loss Pills
A groundbreaking study from Adelaide University is raising questions about SNAC, the ingredient making oral weight-loss drugs like semaglutide tablets viable. In a 21-day animal model, repeated SNAC exposure linked to lower beneficial gut bacteria, reduced protective compounds, and elevated inflammation markers. As tablet versions gain popularity, experts call for more research on this component's full impact.
6 min read
Tirzepatide in Mounjaro Cuts Alcohol Intake Over 50%, Study Shows
The weight-loss drug Mounjaro's active ingredient, tirzepatide, is showing promise beyond metabolic health by slashing alcohol intake in animal models. A new study from the University of Gothenburg found it reduced voluntary consumption by over 50%, curbed binge drinking, and prevented relapse. This could signal a new avenue for treating alcohol use disorder through GLP-1/GIP receptor agonism.
6 min read
4 Tips to Maximize Nutritional Goals on GLP-1 Medications
GLP-1 medications like those approved for weight loss can transform your journey, but nutrition plays a key role in maximizing benefits. A pilot clinical trial by Atkins shows that pairing GLP-1s with higher protein and fiber helps maintain healthier body composition. These 4 tips—fiber, protein, hydration, and small meals—can help you feel energized and supported.
5 min read
GLP-1 Drugs' Wide Reach: Beyond Weight Loss to Economy
GLP-1 drugs such as Ozempic and Wegovy have surged in popularity, with one in eight U.S. adults using them for weight loss or chronic conditions. Beyond shedding pounds, these medications are disrupting economies by curbing appetites and cravings. This guide dives into the clinical mechanisms and real-world impacts on food, fashion, fitness, and beyond.
4 min read
Gut-Brain Connection: How Gut Health Impacts Neurodegenerative Disease Risk
New research highlights the critical role of the gut-brain-immune axis in neurodegenerative diseases. Understanding this connection could unlock new approaches for prevention and treatment. Read on for key insights!
4 min read